Comparison of Segmentectomy Versus Lobectomy for Lung Adenocarcinoma ≤ 2cm — Stella

Clinical trial discovery in plain English. Data sourced from ClinicalTrials.gov.

About Browse conditions ClinicalTrials.gov ↗

Stella is not a medical provider and does not give medical advice. AI-generated summaries are for informational purposes only. Always consult your doctor before making any healthcare decisions.

Comparison of Segmentectomy Versus Lobectomy for Lung Adenocarcinoma ≤ 2cm — Stella

Recruiting

Back to Lung Adenocarcinoma trials

Trial locations(1 site)

China

Shanghai Pulmonary Hospital, Yangpu, Shanghai Municipality

Key details

Sponsor

Shanghai Pulmonary Hospital, Shanghai, China

Enrollment target

~446 participants

Started

August 2019

Primary completion

April 2028

Age range

20 Years – 79 Years

Last updated July 2023

Interested in joining?

Tell us you're interested and we'll help connect you with the research team. We'll never share your email without your permission.

Your name

Email address

Stella acts as an intermediary. Researcher contact info is never exposed.

Follow this trial

Get notified in plain English when this trial's status changes. No account required.

View full record on ClinicalTrials.gov